Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.
Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.
First NCI Director To Resign Due To Presidential Election?
EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.
Perot Systems To Provide IT Support For US Oncology Enterprise Applications.
Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.
Firm Wins Patent For Method, Apparatus For Cryoablation.
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- In the Headlines: Is oncology ready to move away from animal testing?
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?